Literature DB >> 20499226

Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative.

Martin J D Clift1, Peter Gehr, Barbara Rothen-Rutishauser.   

Abstract

Despite the many proposed advantages related to nanotechnology, there are increasing concerns as to the potential adverse human health and environmental effects that the production of, and subsequent exposure to nanoparticles (NPs) might pose. In regard to human health, these concerns are founded upon the plethora of knowledge gained from research relating to the effects observed following exposure to environmental air pollution. It is known that increased exposure to environmental air pollution can cause reduced respiratory health, as well as exacerbate pre-existing conditions such as cardiovascular disease and chronic obstructive pulmonary disease. Such disease states have also been associated with exposure to the NP component contained within environmental air pollution, raising concerns as to the effects of NP exposure. It is not only exposure to accidentally produced NPs however, which should be approached with caution. Over the past decades, NPs have been specifically engineered for a wide range of consumer, industrial and technological applications. Due to the inevitable exposure of NPs to humans, owing to their use in such applications, it is therefore imperative that an understanding of how NPs interact with the human body is gained. In vivo research poses a beneficial model for gaining immediate and direct knowledge of human exposure to such xenobiotics. This research outlook however, has numerous limitations. Increased research using in vitro models has therefore been performed, as these models provide an inexpensive and high-throughput alternative to in vivo research strategies. Despite such advantages, there are also various restrictions in regard to in vitro research. Therefore, the aim of this review, in addition to providing a short perspective upon the field of nanotoxicology, is to discuss (1) the advantages and disadvantages of in vitro research and (2) how in vitro research may provide essential information pertaining to the human health risks posed by NP exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499226     DOI: 10.1007/s00204-010-0560-6

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  32 in total

Review 1.  Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective.

Authors:  Renata Behra; Laura Sigg; Martin J D Clift; Fabian Herzog; Matteo Minghetti; Blair Johnston; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  J R Soc Interface       Date:  2013-07-24       Impact factor: 4.118

2.  Biomimetics of the pulmonary environment in vitro: A microfluidics perspective.

Authors:  Janna Tenenbaum-Katan; Arbel Artzy-Schnirman; Rami Fishler; Netanel Korin; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

Review 3.  The asbestos-carbon nanotube analogy: An update.

Authors:  Agnes B Kane; Robert H Hurt; Huajian Gao
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-28       Impact factor: 4.219

4.  Biomimetics of fetal alveolar flow phenomena using microfluidics.

Authors:  Janna Tenenbaum-Katan; Rami Fishler; Barbara Rothen-Rutishauser; Josué Sznitman
Journal:  Biomicrofluidics       Date:  2015-02-17       Impact factor: 2.800

5.  Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dots.

Authors:  Lisa A McConnachie; Collin C White; Dianne Botta; Megan E Zadworny; David P Cox; Richard P Beyer; Xiaoge Hu; David L Eaton; Xiaohu Gao; Terrance J Kavanagh
Journal:  Nanotoxicology       Date:  2012-01-20       Impact factor: 5.913

6.  Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions.

Authors:  Iris R Bell; John A Ives; Wayne B Jonas
Journal:  Dose Response       Date:  2013-11-07       Impact factor: 2.658

7.  How should the completeness and quality of curated nanomaterial data be evaluated?

Authors:  Richard L Marchese Robinson; Iseult Lynch; Willie Peijnenburg; John Rumble; Fred Klaessig; Clarissa Marquardt; Hubert Rauscher; Tomasz Puzyn; Ronit Purian; Christoffer Åberg; Sandra Karcher; Hanne Vriens; Peter Hoet; Mark D Hoover; Christine Ogilvie Hendren; Stacey L Harper
Journal:  Nanoscale       Date:  2016-05-04       Impact factor: 7.790

8.  Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery.

Authors:  Patricia Ojer; Adela López de Cerain; Paloma Areses; Ivan Peñuelas; Juan M Irache
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

9.  Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.

Authors:  Erika N Cline; Ming-Hsin Li; Seok Ki Choi; Jeffrey F Herbstman; Neha Kaul; Edgar Meyhöfer; Georgios Skiniotis; James R Baker; Ronald G Larson; Nils G Walter
Journal:  Biomacromolecules       Date:  2013-02-21       Impact factor: 6.988

10.  Microbiome as an Immunological Modifier.

Authors:  Manoj Kumar; Parul Singh; Selvasankar Murugesan; Marie Vetizou; John McCulloch; Jonathan H Badger; Giorgio Trinchieri; Souhaila Al Khodor
Journal:  Methods Mol Biol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.